Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18–60 and 60+ Age Cohorts
We present the results of a randomized, double-blind, placebo-controlled, multi-center clinical trial phase I/II of the tolerability, safety, and immunogenicity of the inactivated whole virion concentrated purified coronavirus vaccine CoviVac in volunteers aged 18–60 and open multi-center comparativ...
Full description
Bibliographic Details
| Main Authors: |
Ilya V. Gordeychuk,
Liubov I. Kozlovskaya,
Aleksandra A. Siniugina,
Nadezhda V. Yagovkina,
Vladimir I. Kuzubov,
Konstantin A. Zakharov,
Viktor P. Volok,
Maria S. Dodina,
Larissa V. Gmyl,
Natalya A. Korotina,
Rostislav D. Theodorovich,
Yulia I. Ulitina,
Dmitry I. Vovk,
Marina V. Alikova,
Anna A. Kataeva,
Anna V. Kalenskaya,
Irina V. Solovjeva,
Elena V. Tivanova,
Larissa Y. Kondrasheva,
Antonina A. Ploskireva,
Vasiliy G. Akimkin,
Ksenia A. Subbotina,
Georgy M. Ignatyev,
Anastasia K. Korduban,
Elena Y. Shustova,
Ekaterina O. Bayurova,
Alla S. Zhitkevich,
Daria V. Avdoshina,
Anastasia N. Piniaeva,
Anastasia A. Kovpak,
Liliya P. Antonova,
Yulia V. Rogova,
Anna A. Shishova,
Yury Y. Ivin,
Svetlana E. Sotskova,
Konstantin A. Chernov,
Elena G. Ipatova,
Ekaterina A. Korduban,
Aydar A. Ishmukhametov |
|---|
| Format: | Article
|
|---|
| Language: | English |
|---|
| Published: |
MDPI AG
2023-08-01
|
|---|
| Series: | Viruses
|
|---|
| Subjects: | |
|---|
| Online Access: | https://www.mdpi.com/1999-4915/15/9/1828
|
|---|